PRFX PRF Technologies Ltd. - Ordinary Shares

NASDAQ · Pharmaceuticals
$0.91
Price · Aug 19, 2026

PRFX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.91
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$1 – $5

PRFX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
PRFX
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
PRFX
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
PRFX
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
PRFX
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
PRFX
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
PRFX
Peer Median

PRFX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

SELL 6 analysts
  • Strong Buy 0 0.0%
  • Buy 0 0.0%
  • Hold 3 50.0%
  • Sell 1 16.7%
  • Strong Sell 2 33.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-20.2%
Period EPS Actual EPS Est Surprise
June 30, 2024 $-213.60 $-127.30 -86.3%
March 31, 2024 $-326.40 $-293.76 -32.6%
Dec. 31, 2023 $-373.20 $-182.38 -190.8%
Sept. 30, 2023 $57.60 $-171.36 229.0%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
PRFX
SPRC
RDHL

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 8 filers · $249K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
4 0 3 0

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.

Institution Value Shares % of tracked 13F Type
Yorkville Advisors Global, LP $111,922 81,103 45.02% Shares
JANE STREET GROUP, LLC $78,997 57,244 31.77% Shares
CITADEL ADVISORS LLC $39,434 28,575 15.86% Shares
UBS Group AG $14,373 10,415 5.78% Shares
MORGAN STANLEY $3,839 2,782 1.54% Shares
OSAIC HOLDINGS, INC. $53 40 0.02% Shares
Rockefeller Capital Management L.P. $1 1 0.00% Shares
ROYAL BANK OF CANADA $0 233 0.00% Shares

Activists & 5%+ owners 2 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Undisclosed reporting person, Undisclosed reporting person Aug. 29, 2024 Initial filing SEC
Undisclosed reporting person, Undisclosed reporting person Aug. 26, 2024 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.